ISRCTN73106458进行中（未招募）未知
MetAbolic, Immunological and Pathological Factors in Kidney Disease
niversity Hospitals of Leicester NHS Trust0 个研究点目标入组 38 人开始时间: 2018年5月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 38
研究概览
简要总结
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35090033/ (added 18/09/2023) Results article in https://pubmed.ncbi.nlm.nih.gov/35452395/ (added 18/09/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35029054/ (added 18/09/2023)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Kidney disease patient:
- •1. Established CKD according to these guidelines : http://www.gpnotebook.co.uk/simplepage.cfm?ID=x20140903131721906919
- •or identified with the IMPAKT tool : http://www.impakt.org.uk/HOME-459.html
- •2. Willing and able to give informed consent and comply with the study protocol
- •3. Male or female
- •4. Aged 18 years or above
- •Healthy control:
- •1. Willing and able to give informed consent and comply with the study protocol.
- •2. Male or female
- •3. Aged 18 years or above.
排除标准
- •Both kidney disease patients and healthy controls:
- •1. Age <18 years
- •2. Any other significant disease or disorder which, in the opinion of the patient’s own clinician, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study.
- •3. Inability to give informed consent or comply with the protocol for any reason.
研究者
相似试验
招募中
不适用
Metabolic phenotype in COPDCTRI/2018/01/011441Chest Research Foundation75
已完成
不适用
Identification of metabolomic biomarkers to assess dietary exposure in free-living adultsTopic: Metabolic and endocrine disordersSubtopic: Metabolic and Endocrine (all Subtopics)Disease: Metabolic & Endocrine (not diabetes)Nutritional, Metabolic, EndocrineISRCTN88921234ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)51
已完成
不适用
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its ResolutionCovid19NCT04664023Poitiers University Hospital130
进行中（未招募）
1 期
Assessment of Metabolic and pathological Response to Treatment with Radio-chemotherapy (RCT) and Immunotherapy (ImT) before Surgery in locally advanced Esophageal and gastro-esophageal junction cancer: ARTemIS-Eso, a three-level, open-label, phase I-II studyAdenocarcinomas of the esophagus or gastro-esophageal junction and squamous cell carcinoma of the esophagus.MedDRA version: 20.0 Level: PT Classification code 10061534 Term: Oesophageal squamous cell carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10030137 Term: Oesophageal adenocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-000935-42-BEInstitut Jules Bordet100
已完成
不适用
Evaluating an exercise game session in the ExerCubeISRCTN43067716Martin Luther University Halle-Wittenberg28